Literature DB >> 3810043

Stages in LAV/HTLV-III lymphadenitis. I. Histological and immunohistological classification.

G Pallesen, J Gerstoft, L Mathiesen.   

Abstract

Lymph nodes from 40 homosexuals with persistent, generalized lymphadenopathy were studied for histological and immunohistological changes and classified into histological stages based on the progressive destruction of lymph node follicles in association with progression of the disease. Three patterns were recognized: stage I was characterized by follicular hyperplasia, mantle zone depletion, and follicular fragmentation in the absence of vasculitis, stage II by signs of follicular involution, and stage III by depletion of follicles and dendritic reticulum cells with development of diffuse pattern. The T zone was gradually depleted of CD4-positive lymphocytes, but on further progression, lymphocytic depletion (which also involved the CD8-positive cells) and fibrosis prevailed. The 40 lymph nodes from homosexuals were classified as stage I in 18 cases, stage II in 11, and stage III in 10. One case did not fulfil our histological criteria for LAV/HTLV-III lymphadenitis, although this patient was seropositive. Convincing correlation was found between histological stages and clinical and laboratory data. The triad of follicular hyperplasia, mantle zone depletion, and follicular fragmentation, in the absence of vasculitis, appears pathognomonic for the early disease. The diffuse pattern, however, may be seen in different disease entities.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3810043     DOI: 10.1111/j.1365-3083.1987.tb01049.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  Immunocytochemical analysis of lymph node aspirates in patients with human immunodeficiency virus infection.

Authors:  J Oertel; B Oertel; H Lobeck; D Huhn
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

Review 2.  B-cell responses to HIV infection.

Authors:  Susan Moir; Anthony S Fauci
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

3.  Antibodies against the major core protein p24 of human immunodeficiency virus: relation to immunological, clinical and prognostic findings.

Authors:  B O Lindhardt; J Gerstoft; B Hofmann; G Pallesen; L Mathiesen; E Dickmeiss; K Ulrich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

4.  The lymphocytosis-promoting agent pertussis toxin affects virus burden and lymphocyte distribution in the SIV-infected rhesus macaque.

Authors:  C D Pauza; P W Hinds; C Yin; T S McKechnie; S B Hinds; M S Salvato
Journal:  AIDS Res Hum Retroviruses       Date:  1997-01-01       Impact factor: 2.205

5.  Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patients.

Authors:  M J Boyle; M F Berger; M Tschuchnigg; J E Valentine; B G Kennedy; M Divjak; D A Cooper; J J Turner; R Penny; W A Sewell
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

6.  Persistent human immunodeficiency virus type 1 infection of monoblastoid cells leads to accumulation of self-integrated viral DNA and to production of defective virions.

Authors:  C D Pauza; J Galindo
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

7.  Human immunodeficiency virus infection of monoblastoid cells: cellular differentiation determines the pattern of virus replication.

Authors:  C D Pauza; J Galindo; D D Richman
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.